Skip to content
Threat Brief

← All advisories

CVE-2026-123051

Low 1.2No known exploitationFix status unknown

Title not yet published

Record last updated

CVSS score

1.2

Low on a 0 to 10 scale

EPSS, chance of exploitation in 30 days

0.2%

Higher than 8% of scored CVEs. A prediction, not evidence.

CISA remediation deadline

None

Not in the KEV catalog

Description

The REV.exe module distributed with Farmasimplex contains embedded OAuth client credentials for integration with the IZS platform. An attacker with access to the executable could extract and reuse the credentials, potentially leading to unauthorized access to integration resources or manipulation of associated information, depending on the privileges granted and authentication controls in place.

Weakness: CWE-798

Patching and mitigation

Patch status
Unknown: no source documents a fix
Mitigation
None documented
Vendor guidance
No vendor link on record

Affected products

No affected products documented yet.

Timeline

  1. No dated events documented yet.

Vendor guidance and references